NHS-PEG4-GGFG-DXD is a unique tetrapeptide linker-payload used for the generation of antibody-drug conjugates (ADCs). The NHS is reactive with amine moieties. DXd, a derivative of exatecan, is a novel DNA topoisomerase I inhibitor that may be used as an ADC payload. The PEG4 units boost the solubility of the compound in aqueous media. Reagent grade, for research use only.
Usually ships within 24 hours.